KWKevin A. Welle

Kevin A. Welle

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kevin A. Welle has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mass spectrometric analysis of free methionine oxidation levels in E. coli

    by Maria Ahmed, Philip Bellomio, Bruno Manta, Kyle Swovick, Kevin A. Welle, Jennifer R. Hryhorenko, Sina Ghaemmaghami

    Oxidation of free methionine plays important roles in cellular redox homeostasis, yet its accurate quantification has been hindered by methodological challenges. Here, we introduce free Methionine Oxidation by Blocking (fMObB), a mass spectrometry–based method that enables accurate measurement of the fractional oxidation of free methionines. Applying fMObB to Escherichia coli , we quantify free methionine oxidation under basal and oxidative stress conditions, and in strains lacking methionine sulfoxide reductases. We find that during oxidative stress, free methionines exhibit higher oxidation levels than protein-bound methionines and that methionine sulfoxide reductases play a central role in maintaining reduced free methionine pools. Together, this work establishes fMObB as a generalizable strategy for probing free methionine redox states in cellular systems.

  • Open Access

    Structural proteomics of the human ubiquitinome

    by Anushka Jain, Naiyareen Mayeen, Michael E. Meadow, Nino Kalandadze, Kyle Swovick, Kevin A. Welle, Jennifer R. Hryhorenko, Sina Ghaemmaghami

    The proteasome maintains the integrity of eukaryotic proteomes by selectively degrading ubiquitinated protein substrates. Ubiquitination targets a wide range of substrates for degradation, including translationally stalled nascent chains, misfolded proteins, and properly folded but short-lived proteins destined for regulatory degradation. Distinct structural features and ubiquitination patterns across these classes of substrates remain largely undefined. In this study, we combine structural proteomics and time-resolved isotopic labeling to profile the modification sites, dynamics, and conformational properties of the human ubiquitinome. We show that proteins undergoing rapid proteasomal degradation are ubiquitinated at lysine residues that are normally buried within structured regions of their native conformations. We provide proteome-wide evidence that this high-flux subset of the ubiquitinome is enriched in newly synthesized proteins that have non-native conformations. Together, our findings demonstrate how the lack of structural integrity of misfolded nascent proteins influences their ubiquitination patterns and ensures proper proteasomal degradation. Significance Statement: Protein degradation by the ubiquitin–proteasome system (UPS) is central to maintaining cellular protein quality control, yet the structural and kinetic determinants that govern which proteins are targeted for degradation remain poorly defined. Using deep-coverage structural proteomics combined with metabolic labeling, we show that ubiquitination events can be categorized into two broad classes with distinct properties: those at buried lysines within nascent misfolded proteins that lead to rapid proteasomal degradation, and those at exposed lysines in mature proteins that are associated with slower turnover or regulatory functions. This proteome-wide partitioning provides structural insights into how the UPS targets defective nascent and mature proteins for proteasomal clearance.

  • Open Access

    Enzymatic synthesis of isotopically labeled hydrogen peroxide for mass spectrometry-based applications

    by Margaret Hoare, Ruiyue Tan, Isabella Militi, Kevin A. Welle, Kyle Swovick, Jennifer R. Hryhorenko, Sina Ghaemmaghami

    Methionine oxidation is involved in multiple biological processes including protein misfolding and enzyme regulation. However, it is often challenging to measure levels of methionine oxidation by mass spectrometry, in part due to the prevalence of artifactual oxidation that occurs during sample preparation and ionization steps of typical proteomic workflows. Isotopically labeled hydrogen peroxide (H 2 18 O 2 ) can be used to block unoxidized methionines and enable accurate measurement of in vivo levels of methionine oxidation. However, H 2 18 O 2 is an expensive reagent that can be difficult to obtain from commercial sources. Here, we report a method for synthesizing H 2 18 O 2 in house. Glucose oxidase catalyzes the oxidation of β-D-glucose and produces hydrogen peroxide in the process. We took advantage of this reaction to enzymatically synthesize H 2 18 O 2 from 18 O 2 and assessed its concentration, purity, and utility in measuring methionine oxidation levels by mass spectrometry.

  • Open Access

    Proteome Birthdating Reveals Age-Selectivity of Protein Ubiquitination

    by Michael E. Meadow, Sarah Broas, Margaret Hoare, Fatemeh Alimohammadi, Kevin A. Welle, Kyle Swovick, Jennifer R. Hryhorenko, John C. Martinez, Seyed Ali Biashad, Andrei Seluanov, et al.


  • Open Access

    Ischemic Stroke Thrombus Perviousness Is Associated with Distinguishable Proteomic Features and Susceptibility to ADAMTS13-Augmented Thrombolysis

    by Derrek Schartz, Sajal Medha K. Akkipeddi, Redi Rahmani, Nathaniel Ellens, Clifton Houk, Gurkirat Singh Kohli, Logan Worley, Kevin Welle, Tarun Bhalla, Thomas Mattingly, et al.

    BACKGROUND AND PURPOSE: Perviousness is the differential attenuation on CT of an intracranial arterial occlusive thrombus before and after IV contrast administration. While perviousness/permeability has been shown to be related to various clinical outcomes and reflects histopathologic composition, it remains unclear whether perviousness is also associated with differences in proteomic composition. MATERIALS AND METHODS: Retrieved clots from 59 patients were evaluated with quantitative mass spectrometry. Proteomic differences between high-perviousness (≥11 HU) and low-perviousness (P = .039, z = 1.176) and hemoglobin subunit ζ (P = .046, z = 1.68) in pervious clots. Additionally, proteins involved in platelet cytoskeleton remodeling (tropomyosin α-3-chain) and granule secretion/aggregation (synaptotagmin-like protein 4/FC region receptor II-a) were associated with increasing perviousness (P < .006), among numerous other proteins. Monocyte/macrophage-associated proteins (apoptosis-associated specklike protein containing a CARD/SAMHD1) were also depleted in pervious emboli (P < .002). Ex vivo lysis indicated that pervious clots were more susceptible to ADAMTS13-augmented tPA thrombolysis compared with impervious clots (P < .05), though without differences in deoxyribonuclease digestion. CONCLUSIONS: Thrombus perviousness is associated with complex proteomic features, including differential abundance of platelet-related proteins in highly permeable clots with monocyte/macrophage depletion. This association may help to explain why highly pervious thrombi were also found more susceptible to ADAMTS13-augmented thrombolysis.


  • Open Access

    Long lifetime and tissue-specific accumulation of lamin A/C in Hutchinson–Gilford progeria syndrome

    by John Hasper, Kevin Welle, Kyle Swovick, Jennifer Hryhorenko, Sina Ghaemmaghami, Abigail Buchwalter

    LMNA mutations cause laminopathies that afflict the cardiovascular system and include Hutchinson-Gilford progeria syndrome. The origins of tissue specificity in these diseases are unclear as the lamin A/C proteins are broadly expressed. We show that LMNA transcript levels are not predictive of lamin A/C protein levels across tissues and use quantitative proteomics to discover that tissue context and disease mutation each influence lamin A/C protein’s lifetime. Lamin A/C’s lifetime is an order of magnitude longer in the aorta, heart, and fat, where laminopathy pathology is apparent, than in the liver and intestine, which are spared from the disease. Lamin A/C is especially insoluble in cardiovascular tissues, which may limit degradation and promote protein stability. Progerin is even more long lived than lamin A/C in the cardiovascular system and accumulates there over time. Progerin accumulation is associated with impaired turnover of hundreds of abundant proteins in progeroid tissues. These findings identify impaired lamin A/C protein turnover as a novel feature of laminopathy syndromes.


  • Open Access

    Proteome birthdating reveals age-selectivity of protein ubiquitination

    by Michael E. Meadow, Sarah Broas, Margaret Hoare, Fatemeh Alimohammadi, Kevin A. Welle, Kyle Swovick, Jennifer R. Hryhorenko, John C. Martinez, Seyed Ali Biashad, Andrei Seluanov, et al.

    Within a cell, proteins have distinct and highly variable half-lives. As a result, the molecular ages of proteins can range from seconds to years. How the age of a protein influences its environmental interactions is a largely unexplored area of biology. To investigate the age-selectivity of cellular pathways, we developed a methodology termed “proteome birthdating” that barcodes proteins based on their time of synthesis. We demonstrate that this approach provides accurate measurements of protein turnover kinetics without the requirement for multiple kinetic time points. As a first use case of the birthdated proteome, we investigated the age distribution of the human ubiquitinome. Our results indicate that the vast majority of ubiquitinated proteins in a cell consist of newly synthesized proteins and that these young proteins constitute the bulk of the degradative flux through the proteasome. Rapidly ubiquitinated nascent proteins are enriched in cytosolic subunits of large protein complexes. Conversely, proteins destined for the secretory pathway and vesicular transport have older ubiquitinated populations. Our data also identified a smaller subset of very old ubiquitinated cellular proteins that do not appear to be targeted to the proteasome for rapid degradation. Together, our data provide an age census of the human ubiquitinome and establish proteome birthdating as a robust methodology for investigating the protein age-selectivity of diverse cellular pathways. Significance Statement: Cellular proteins have widely different ages - whereas some have been recently synthesized, others have existed in the cell for days or even years. How a protein’s age influences its functions and interactions is largely unknown because it is difficult to globally differentiate proteins based on their time of synthesis. To address this challenge, we developed an analytical method named “proteome birthdating” that can partition cellular proteins into multiple discernible age groups. As an example application, we used proteome birthdating to examine the protein age-selectivity of the ubiquitin proteasome system, a major protein degradation pathway in eukaryotes. Our results show that proteins destined for degradation by this pathway consist of either particularly young or particularly old proteins, with the former being the predominant population. Together, our results establish proteome birthdating as a useful approach for analyzing the turnover of proteins and investigating the functional consequences of their age.

  • Open Access

    Methionine Alkylation as an Approach to Quantify Methionine Oxidation Using Mass Spectrometry

    by Margaret Hoare, Ruiyue Tan, Kevin A. Welle, Kyle Swovick, Jennifer R. Hryhorenko, Sina Ghaemmaghami

    Post-translational oxidation of methionine residues can destabilize proteins or modify their functions. Although levels of methionine oxidation can provide important information regarding the structural integrity and regulation of proteins, their quantitation is often challenging as analytical procedures in and of themselves can artifactually oxidize methionines. Here, we develop a mass spectrometry-based method called Methionine Oxidation by Blocking with Alkylation (MObBa) that quantifies methionine oxidation by selectively alkylating and blocking unoxidized methionines. Thus, alkylated methionines can be used as a stable proxy for unoxidized methionines. Using proof of concept experiments, we demonstrate that MObBa can be used to measure methionine oxidation levels within individual synthetic peptides and on proteome-wide scales. MObBa may provide a straightforward experimental strategy for mass spectrometric quantitation of methionine oxidation. Significance Statement Over time, cellular proteins can become oxidatively damaged by reactive oxygen species (ROS). A residue that is particularly prone to oxidative damage is methionine. Here, we develop and validate a methodology for detecting and quantifying levels of methionine oxidation by mass spectrometry. This approach has a number of practical advantages over methods currently available for analysis of methionine oxidation. The ability to accurately quantify methionine oxidation will provide important insights into factors that influence protein homeostasis within a cell.


  • Open Access

    O-016 Thrombus permeability is associated with distinct proteomic features and differential susceptibility to adamts13 thrombolysis

    by D Schartz, S Akkipeddi, N Ellens, R Rahmani, G Kohli, R Ismail, S Chittaranjan, K Welle, T Bhalla, T Mattingly, et al.

    Background and Purpose Acute ischemic stroke (AIS) thrombus perviousness/permeability has been shown to be related with various clinical outcomes and reflect histopathologic composition. However, it remains unclear if perviousness is also associated with differences in proteomic composition. Materials and Methods Mechanical thrombectomy retrieved clots from 59 patients were evaluated with quantitative mass spectrometry. Proteomic differences between high perviousness (>11 Hounsfield Units; HU) and low perviousness (Results From 85,244 distinct patients who had an MRI of the spine, 2,791 (3.3%) were identified with perineural cysts. Thrombus perviousness was negatively related to certain constituent proteins, including macrophage marker CD14 (P=0.039, Z=1.176), monocyte/macrophage associated proteins (PYCARD/ASC and SAMHD1) (P < 0.002), and hemoglobin subunit zeta (P=0.046, Z=1.68). A positive association between perviousness and other proteins was observed, including platelet cytoskeleton remodeling (TPM3) and platelet granule secretion/aggregation (SYTL4/FcγRIIA) (P < 0.006). Ex vivo lysis assay indicated that highly pervious clots were more susceptible to ADAMTS13-augmented tPA thrombolysis compared to low pervious clots (P < 0.05), though without differences to DNase digestion. Conclusion Thrombus permeability is associated with distinguishable proteomics features, including greater abundance of platelet-related proteins in highly permeable clots and monocyte/macrophages in less permeable clots. These findings also suggest that highly pervious thrombi may be differentially susceptible to ADAMTS13 augmented thrombolysis. Disclosures D. Schartz: None. S. Akkipeddi: None. N. Ellens: None. R. Rahmani: None. G. Kohli: None. R. Ismail: None. S. Chittaranjan: None. K. Welle: None. T. Bhalla: None. T. Mattingly: None. C. Morrell: None. M. Bender: None.